miércoles, 22 de enero de 2025

Efficacy and safety of tezepelumab versus placebo in adults with moderate to very severe chronic obstructive pulmonary disease (COURSE): a randomised, placebo-controlled, phase 2a trial

https://www.thelancet.com/journals/lanres/article/PIIS2213-2600(24)00324-2/abstract?utm_campaign=update-lanres&utm_medium=email&dgcid=hubspot_update_feature_updatealerts_lanres&_hsenc=p2ANqtz-_gBmTdXk_9uHKBtb8vgFgxpgR6a77A5EpkQAhfcsnBGj6Zm9NqFJaEjk7f1jrqcUPk2UuADstb9Z7P_-wOSpSaBhQdvw&_hsmi=343282117&utm_content=343275138&utm_source=hs_email

The UK Tobacco and Vapes Bill: a historic opportunity The Lancet Respiratory Medicine

https://www.thelancet.com/journals/lanres/issue/vol13no1/PIIS2213-2600(24)X0013-2

Immunotherapy boosts chemotherapy in rare urological cancers An immune checkpoint inhibitor and chemotherapy extended progression-free survival in late-stage small cell bladder and prostate cancers.

https://www.drugdiscoverynews.com/immunotherapy-boosts-chemotherapy-in-rare-urological-cancers-16203

How gut microbiota impacts childhood obesity

https://www.news-medical.net/news/20250121/How-gut-microbiota-impacts-childhood-obesity.aspx

Higher dietary fatty acid intake linked to increased kidney stone risk

https://www.news-medical.net/news/20250122/Higher-dietary-fatty-acid-intake-linked-to-increased-kidney-stone-risk.aspx

Surgery reduces accident risk in sleep apnea patients

https://www.news-medical.net/news/20250122/Surgery-reduces-accident-risk-in-sleep-apnea-patients.aspx

GLP1RA medications linked to behavioral side effects in type 2 diabetes and obesity

https://www.news-medical.net/news/20250122/GLP1RA-medications-linked-to-behavioral-side-effects-in-type-2-diabetes-and-obesity.aspx